Sedation for Diagnostic Gastroscopy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Sedation for Diagnostic Gastroscopy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT06349564

Implementing Virtual Reality (VR) to Reduce Sedation

The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedati…

United States10 participantsStarted 2024-12-09

Treatment: Pico 4 Enterprise headset with noise cancelling headphones

RecruitingPhase 4

NCT06614036

Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial

Rationale Midazolam is known for its safety, effectiveness for procedural sedation during gastrointestinal (GI) endoscopy and is used as standard sedative by en…

Netherlands148 participantsStarted 2024-10-21

Treatment: Remimazolam, Midazolam

Sedation for Diagnostic Gastroscopy

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Implementing Virtual Reality (VR) to Reduce Sedation

Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial

All recent trials (2 shown)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Implementing Virtual Reality (VR) to Reduce Sedation

Remimazolam Versus Midazolam for Sedation During Upper GI Endoscopy: a Randomized Controlled Trial

All recent trials (2 shown)